Avacta Acquires Coris Bioconcept
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
Read MorePosted by Melanie Hamilton-Basich | Jun 2, 2023 | Company News |
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Point-of-Care |
Orchard Software has partnered with Emerus Holdings Inc. for implementation of its Orchard Point-of-Care testing solution.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Molecular Diagnostics |
GT Molecular, Inc. is entering the cancer molecular assay market with multi-target PCR kits featuring quality control metrics.
Read MorePosted by Chris Wolski | May 30, 2023 | POC Rapid Assays |
The CDC’s OneLab TEST is designed for anyone who performs or coordinates diagnostic testing at non-laboratory sites.
Read MorePosted by Melanie Hamilton-Basich | May 29, 2023 | Molecular Diagnostics |
Roche showcased some of its new and future innovative laboratory solutions and digital diagnostics at this year’s WorldLab-EuroMedLab 2023.
Read More